Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$244.08
+1.3%
$235.32
$211.43
$387.99
$6.56B0.93462,659 shs268,178 shs
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
$107.68
$106.90
$100.01
$112.30
N/A-0.02106 shsN/A
GN Store Nord stock logo
GNNDY
GN Store Nord
$45.86
-1.7%
$43.45
$36.83
$84.62
$2.35B1.7757 shs103 shs
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
$80.74
+0.2%
$85.11
$73.11
$126.89
$5.57B0.111.01 million shs999,230 shs
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
+1.20%+5.35%+5.97%+0.31%-12.25%
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
0.00%-0.90%+2.85%-1.75%-1.21%
GN Store Nord stock logo
GNNDY
GN Store Nord
-1.65%+1.55%+6.65%-7.48%-47.14%
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
+0.24%+2.22%+6.57%-16.04%+2.83%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
4.804 of 5 stars
3.44.00.04.23.82.51.9
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
N/AN/AN/AN/AN/AN/AN/AN/A
GN Store Nord stock logo
GNNDY
GN Store Nord
N/AN/AN/AN/AN/AN/AN/AN/A
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
4.3346 of 5 stars
3.51.00.04.22.02.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
2.75
Moderate Buy$324.2532.85% Upside
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
2.00
HoldN/AN/A
GN Store Nord stock logo
GNNDY
GN Store Nord
1.67
ReduceN/AN/A
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
3.00
Buy$130.5061.63% Upside

Current Analyst Ratings Breakdown

Latest GNNDY, BIO, DSRLF, and LNTH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/23/2025
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$122.00 ➝ $109.00
6/9/2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$260.00 ➝ $245.00
5/8/2025
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$127.00 ➝ $117.00
5/2/2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$355.00 ➝ $310.00
5/2/2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$400.00 ➝ $350.00
5/2/2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$409.00 ➝ $392.00
4/28/2025
GN Store Nord stock logo
GNNDY
GN Store Nord
Kepler Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/17/2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$320.00 ➝ $270.00
(Data available from 6/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.57B2.59$10.53 per share23.19$234.52 per share1.04
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
$1.24BN/A$9.09 per share11.85N/AN/A
GN Store Nord stock logo
GNNDY
GN Store Nord
$2.61BN/A$6.71 per share6.83$31.20 per shareN/A
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
$1.53B3.64$7.11 per share11.35$15.65 per share5.16
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-$1.84B-$76.20N/A19.60N/A-85.16%4.32%3.03%7/30/2025 (Estimated)
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
$173.01MN/A0.00N/AN/AN/AN/A7/28/2025 (Estimated)
GN Store Nord stock logo
GNNDY
GN Store Nord
$143.26M$2.4019.117.49N/A4.71%7.92%2.75%8/21/2025 (Estimated)
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
$312.44M$3.5222.9412.80N/A16.55%36.99%20.55%7/30/2025 (Estimated)

Latest GNNDY, BIO, DSRLF, and LNTH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2025Q1 2025
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
$1.64$1.53-$0.11$1.02$377.37 million$372.76 million
5/1/2025Q1 2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$1.73$2.54+$0.81$2.29$573.01 million$585.40 million
4/30/2025Q1 2025
GN Store Nord stock logo
GNNDY
GN Store Nord
N/A$0.21N/A$0.21N/A$562.08 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
N/AN/AN/AN/AN/A
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
N/AN/AN/AN/AN/A
GN Store Nord stock logo
GNNDY
GN Store Nord
N/AN/AN/AN/AN/A
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.18
5.99
4.43
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
N/AN/AN/A
GN Store Nord stock logo
GNNDY
GN Store Nord
0.83
1.14
0.83
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
0.49
5.74
5.46

Institutional Ownership

CompanyInstitutional Ownership
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
65.24%
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
N/A
GN Store Nord stock logo
GNNDY
GN Store Nord
N/A
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
99.06%

Insider Ownership

CompanyInsider Ownership
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
17.06%
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
N/A
GN Store Nord stock logo
GNNDY
GN Store Nord
N/A
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
1.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
7,70027.21 million22.57 millionOptionable
DiaSorin S.p.A. stock logo
DSRLF
DiaSorin
3,186N/AN/ANot Optionable
GN Store Nord stock logo
GNNDY
GN Store Nord
7,347N/AN/ANot Optionable
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
70069.19 million68.15 millionOptionable

Recent News About These Companies

Lantheus Holdings, Inc. (LNTH) - Yahoo Finance

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bio-Rad Laboratories stock logo

Bio-Rad Laboratories NYSE:BIO

$244.08 +3.10 (+1.29%)
As of 06/26/2025 03:58 PM Eastern

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

DiaSorin stock logo

DiaSorin OTCMKTS:DSRLF

$107.68 0.00 (0.00%)
As of 06/25/2025

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

GN Store Nord stock logo

GN Store Nord OTCMKTS:GNNDY

$45.86 -0.77 (-1.65%)
As of 06/26/2025 01:32 PM Eastern

GN Store Nord A/S provides hearing, audio, video, and gaming solutions in Denmark, rest of Europe, North America, and internationally. The company operates through GN Hearing and GN Audio segments. The GN Hearing segment produces and sells hearing instruments and products. The GN Audio segment supplies headsets, video cameras, and speakerphones for professional use and consumer products. It offers its products under the ReSound, Jabra, Beltone, Interton, Danavox, BlueParrott, FalCom, and SteelSeries brands. GN Store Nord A/S was founded in 1869 and is based in Ballerup, Denmark.

Lantheus stock logo

Lantheus NASDAQ:LNTH

$80.74 +0.19 (+0.24%)
Closing price 06/26/2025 04:00 PM Eastern
Extended Trading
$79.25 -1.49 (-1.85%)
As of 06/26/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. The company also offers Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; and PYLARIFY AI, an AI-based medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer. In addition, it develops 1095, a PSMA-targeted iodine-131-labeled small molecule; PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent that targets Tau tangles in Alzheimer's disease; LNTH-1363S, an fibroblast activation protein, alpha targeted, copper-64 labeled PET imaging agent; and flurpiridaz used to assess blood flow to the heart;. It has collaboration agreements with GE Healthcare; NanoMab Technology Limited; Curium; RefleXion Medical, Inc.; POINT; Regeneron Pharmaceuticals, Inc; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.